CLINICAL_TRIALS
trial_result
· 2018-03-22
Clinical Trial Update: A Study of LY2484595 in Patients With High LDL-C or Low HDL-C [Phase 2]
Summary
A Phase 2 study of LY2484595 in patients with dyslipidemia (high LDL-C or low HDL-C) has completed, with results posted on 2018-03-22.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Dyslipidemia | Phase 2 | Status: COMPLETED | Results posted: 2018-03-22